Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Other Non-Current Assets: 2020-2024

Historic Other Non-Current Assets for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $2.1 million.

  • Relay Therapeutics' Other Non-Current Assets rose 6.56% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 6.56%. This contributed to the annual value of $2.1 million for FY2024, which is 21.72% down from last year.
  • Latest data reveals that Relay Therapeutics reported Other Non-Current Assets of $2.1 million as of FY2024, which was down 21.72% from $2.7 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Other Non-Current Assets registered a high of $2.7 million during FY2023, and its lowest value of $878,000 during FY2020.
  • Moreover, its 3-year median value for Other Non-Current Assets was $2.6 million (2022), whereas its average is $2.5 million.
  • Per our database at Business Quant, Relay Therapeutics' Other Non-Current Assets surged by 193.62% in 2021 and then declined by 21.72% in 2024.
  • Relay Therapeutics' Other Non-Current Assets (Yearly) stood at $878,000 in 2020, then spiked by 193.62% to $2.6 million in 2021, then remained steady at $2.6 million in 2022, then grew by 5.00% to $2.7 million in 2023, then fell by 21.72% to $2.1 million in 2024.